Literature DB >> 25921214

CD8+ T cells in Trypanosoma cruzi infection.

Rick L Tarleton1.   

Abstract

Trypanosoma cruzi infection and Chagas disease remains among the most neglected of the neglected tropical diseases. Despite this, studies of the immune response to T. cruzi have provided new insights in immunology and guidance for approaches for prevention and treatment of the disease. T. cruzi represents one of the very best systems in which to study CD8(+) T cell biology; mice, dogs, and primates (and many other mammals) are all natural hosts for this parasite, the robust T cell responses generated in these hosts can be readily monitored using the full range of cutting edge techniques, and the parasite can be easily modified to express (or not) a variety of tags, reporters, immune enhances, and endogenous or model antigens. The infection in most hosts is characterized by vigorous and largely effective immune responses, including CD8(+) T cells capable of controlling T. cruzi at the level of the infected host cells. However, this immune control is only partially effective and most hosts maintain a low level infection for life. This review addresses the interplay of highly effective CD8(+) T cell responses with elaborate pathogen immune evasion mechanisms, including the generation and simultaneous expression of highly variant CD8(+) T cell targets and a host cell invasion mechanisms that largely eludes innate immune detection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921214      PMCID: PMC4654118          DOI: 10.1007/s00281-015-0481-9

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  43 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.

Authors:  Karen Baur; Kay Brinkmann; Marc Schweneker; Juliane Pätzold; Christine Meisinger-Henschel; Judith Hermann; Robin Steigerwald; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription.

Authors:  Silvia Vaena de Avalos; Ira J Blader; Michael Fisher; John C Boothroyd; Barbara A Burleigh
Journal:  J Biol Chem       Date:  2001-10-19       Impact factor: 5.157

4.  Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy.

Authors:  Susana A Laucella; Damián Pérez Mazliah; Graciela Bertocchi; María G Alvarez; Gretchen Cooley; Rodolfo Viotti; María C Albareda; Bruno Lococo; Miriam Postan; Alejandro Armenti; Rick L Tarleton
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

5.  Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.

Authors:  R L Tarleton
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

6.  Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.

Authors:  H P Low; M A Santos; B Wizel; R L Tarleton
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

7.  Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization.

Authors:  Todd A Minning; D Brent Weatherly; Stephane Flibotte; Rick L Tarleton
Journal:  BMC Genomics       Date:  2011-03-07       Impact factor: 3.969

8.  Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Susana A Laucella; María Gabriela Alvarez; Esteban Rodrigo Fernandez; Bruno Lococo; Rodolfo Viotti; Rick L Tarleton; Miriam Postan
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

Review 9.  Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.

Authors:  Diana Martin; Rick Tarleton
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

10.  Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection.

Authors:  Angel M Padilla; Laura J Simpson; Rick L Tarleton
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

View more
  44 in total

1.  Cutting Edge: Augmenting Muscle MHC Expression Enhances Systemic Pathogen Control at the Expense of T Cell Exhaustion.

Authors:  Angela D Pack; Rick L Tarleton
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.

Authors:  Bijay K Jha; Sanjay Varikuti; Abhay R Satoskar; Bradford S McGwire; Gabriella R Seidler; Greta Volpedo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 3.  Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.

Authors:  V Balouz; F Agüero; C A Buscaglia
Journal:  Adv Parasitol       Date:  2016-11-14       Impact factor: 3.870

Review 4.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

5.  Exhausted PD-1+ TOX+ CD8+ T Cells Arise Only in Long-Term Experimental Trypanosoma cruzi Infection.

Authors:  Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

6.  Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.

Authors:  I Bontempi; K Leal; E Prochetto; G Díaz; G Cabrera; A Bortolotti; H R Morbidoni; S Borsuk; O Dellagostin; I Marcipar
Journal:  Clin Exp Immunol       Date:  2020-07-06       Impact factor: 4.330

Review 7.  Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Mol Life Sci       Date:  2016-03-31       Impact factor: 9.261

8.  Induction of Effective Immunity against Trypanosoma cruzi.

Authors:  Tere Williams; Ignacio Guerrero-Ros; Yanfen Ma; Fabiane Matos Dos Santos; Philipp E Scherer; Ruth Gordillo; Aline Horta; Fernando Macian; Louis M Weiss; Huan Huang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 9.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

Review 10.  Putting Infection Dynamics at the Heart of Chagas Disease.

Authors:  Michael D Lewis; John M Kelly
Journal:  Trends Parasitol       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.